SCHEMBL9986372

SCHEMBL9986372

Cc1occc(=O)c1OS(=O)(=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
GAA P10253 1/20 0.54
ALPL P05186 3/20 0.44
MAOB P27338 2/20 0.44
CA12 O43570 1/20 0.44
CA2 P00918 1/20 0.44
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
ALPI P09923 1/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
XBP1 P17861 3/20 0.40
MPI P34949 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
HSP90AA1 P07900 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LDHA P00338 2/20 0.39
PARL Q9H300 1/20 0.39
S1PR2 O95136 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9985987 0.88 CA12 (0.48) LMNAGAACA12CA2KMT2A
SCHEMBL9986257 0.81 ALPL (0.49) LMNAGAAALPLCA12CA2
SCHEMBL22717108 0.77 LMNA (0.48) LMNAGAAKMT2AALDH1A1MAPT
SCHEMBL1560241 0.76 LMNA (0.48) LMNAGAAKMT2AALDH1A1MAPT
SCHEMBL15453076 0.73 LMNA (0.59) LMNAGAAKMT2AALDH1A1MAPT
SCHEMBL9986035 0.71 KDM4E (0.41) LMNAALPLMAOBKMT2ATDP1
SCHEMBL1286018 0.71 ALPL (0.48) LMNAALPLMAOBTDP1ALDH1A1
SCHEMBL7100551 0.70 LMNA (0.54) LMNAGAAKMT2AALDH1A1MAPT
SCHEMBL81547 0.70 LMNA (1.00) LMNAGAAMAOBKMT2AALDH1A1
SCHEMBL9721396 0.69 SMN1; SMN2 (0.63) LMNAGAACA12KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889638-B2 Stimulus-triggered prodrugs THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-11-18 US disclosed
US-20110312905-A1 STIMULUS-TRIGGERED PRODRUGS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312905-A1 STIMULUS-TRIGGERED PRODRUGS PREP, ADAM10, DNPEP LMNA 2510/4885GAA 390/4885ALPL 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.